7,600 Results

Europe Scores!

 Added 1 day ago

Identifying pain, agitation, and delirium – an interactive symposium taking place at ESICM LIVES 2017.

Teva disposes of womens health businesses to CVC Capital Partners Fund VI and to Foundation Consumer Healthcare.

 Added 1 day ago

Teva Pharmaceutical Industries Ltd.,announced it has entered into two agreements to sell the remaining assets of its specialty global women’s...

FDA approves triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), as Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with COPD.-GSK + Innoviva.

 Added 1 day ago

GlaxoSmithKline plc and Innoviva, Inc. announced that the FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under...

New data from Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the HeartLogic Heart Failure Diagnostic to predict impending heart failure (HF) decompensation.- Boston Scientific.

 Added 1 day ago

Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the performance...

Baxter International Inc.has announced the publication of "Fish Oil Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the Evidence" in the Journal of Parenteral and Enteral Nutrition.

 Added 2 days ago

Baxter International Inc.has announced the publication of "Fish Oil Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the...

The FDA has accepted for review a Biologics License Application (BLA) for a biosimilar candidate (TPI-G-CSF) referencing Neupogen (filgrastim).- Adello Biologics.

 Added 2 days ago

Adello Biologics announced that FDA has accepted for review the company’s Biologics License Application (BLA) for a biosimilar candidate (TPI-G-CSF)...

CHMP recommends Cyltezo (adalimumab biosimilar) to treat multiple chronic inflammatory diseases based on clinical equivalence to Humira (adalimumab), the reference product.- Boehringer.

 Added 2 days ago

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Teva sells ParaGard, an intrauterine copper contraceptive device to Cooper Companies for $1.1 billion.

 Added 2 days ago

The Cooper Companies has agreed to buy ParaGard, an intrauterine copper contraceptive brand from Teva Pharmaceutical Industries for $1.1 billion...

FDA approves supplemental indication for Somatuline Depot (lanreotide) in carcinoid syndrome.- Ipsen.

 Added 2 days ago

Ipsen announced that the FDA has approved a supplemental indication for Somatuline Depot (lanreotide) Injection 120 mg for the treatment...

Phase III LEAP 1 trial of BC 3781 (lefamulin) meets primary endpoint in community-acquired bacterial pneumonia.- Nabriva Therapeutics.

 Added 2 days ago

Nabriva Therapeutics announced positive topline results from the BC 3781 (lefamulin) evaluation against pneumonia (LEAP 1) trial, which evaluated the...

Load more